Type I interferon activation in RAS-associated autoimmune leukoproliferative disease (RALD)

Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis

(2020) Hsi-en Ho et al.   Frontiers in Immunology

Novel Proteasome Assembly Chaperone mutations in PSMG2/PAC2, cause the autoinflammatory interferonopathy, CANDLE/PRAAS4

(2019) Adriana A. de Jesus et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children

(2019) Wei Wang et al.   Pediatric Rheumatology

Type I interferon pathway activation in COPA syndrome

(2018) Stefano Volpi et al.   CLINICAL IMMUNOLOGY

DNA-Damage-Induced Type I Interferon Promotes Senescence and Inhibits Stem Cell Function

(2015) Qiujing Yu et al.   Cell Reports

RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia

(2014) N. Lanzarotti et al.   BLOOD

Dependence of Immunoglobulin Class Switch Recombination in B Cells on Vesicular Release of ATP and CD73 Ectonucleotidase Activity

(2013) Francesca Schena et al.   Cell Reports

Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID

(2011) A. V. Sauer et al.   BLOOD

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation

(2010) M. Takagi et al.   BLOOD